EP0423315A4 - Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine - Google Patents

Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine

Info

Publication number
EP0423315A4
EP0423315A4 EP19900907743 EP90907743A EP0423315A4 EP 0423315 A4 EP0423315 A4 EP 0423315A4 EP 19900907743 EP19900907743 EP 19900907743 EP 90907743 A EP90907743 A EP 90907743A EP 0423315 A4 EP0423315 A4 EP 0423315A4
Authority
EP
European Patent Office
Prior art keywords
antigen peptide
dendritic polymer
system useful
multiple antigen
peptide system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900907743
Other languages
English (en)
Other versions
EP0423315A1 (de
Inventor
James P. Tam
Fidel P. Zavala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
New York University NYU
Original Assignee
Rockefeller University
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University, New York University NYU filed Critical Rockefeller University
Publication of EP0423315A1 publication Critical patent/EP0423315A1/de
Publication of EP0423315A4 publication Critical patent/EP0423315A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP19900907743 1989-04-12 1990-04-10 Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine Withdrawn EP0423315A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33685289A 1989-04-12 1989-04-12
US336852 1994-11-08

Publications (2)

Publication Number Publication Date
EP0423315A1 EP0423315A1 (de) 1991-04-24
EP0423315A4 true EP0423315A4 (en) 1991-11-13

Family

ID=23317953

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900907743 Withdrawn EP0423315A4 (en) 1989-04-12 1990-04-10 Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine

Country Status (5)

Country Link
EP (1) EP0423315A4 (de)
JP (1) JPH03503539A (de)
AU (1) AU5649290A (de)
CA (1) CA2031197A1 (de)
WO (1) WO1990011778A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560929A (en) * 1986-08-18 1996-10-01 The Dow Chemical Company Structured copolymers and their use as absorbents, gels and carriers of metal ions
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
IT1241395B (it) * 1990-04-02 1994-01-10 Eniricerche Spa Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
NZ249704A (en) * 1992-02-11 1996-11-26 Jackson H M Found Military Med A two carrier immunogenic construct comprising a 70+ kd molecule conjugated to at least 1 t-dependent antigen, preparation, compositions containing the construct
US5599912A (en) * 1993-09-10 1997-02-04 Coretech, Inc. Compounds and methods for suppressing an immune response to sulfomethoxozale containing substances
DE699079T1 (de) * 1994-03-07 1997-09-25 Dendritech Inc Bioaktive und/oder gezielte dendrimere-konjugate
US5591717A (en) * 1994-04-06 1997-01-07 Rojko; Jennifer L. Branched apogenic peptide for inducing apoptosis
GB2294690B (en) * 1994-11-01 1998-10-28 United Biomedical Inc Peptides effective for diagnosis and detection of hepatitis C infection
GB2308363A (en) * 1995-12-22 1997-06-25 Courtaulds Coatings Dendritic Polymers
AU5812898A (en) * 1996-12-24 1998-08-03 New York University Polyoxime-based anti-malarial vaccines
WO1998031382A1 (en) * 1997-01-21 1998-07-23 New York University Universal t-cell epitopes for anti-malarial vaccines
FR2772770B1 (fr) 1997-12-19 2000-01-28 Oreal Nouveaux composes choisis parmi les polymeres hyperbranches et les dendrimeres ayant un groupement particulier, procede de preparation, utilisation et compositions les comprenant
ITRM20010563A1 (it) * 2001-09-14 2003-03-14 Univ Siena Peptidi antigenici multipli come antidoti nell'intossicazione da veleno di serpente.
PT1940916T (pt) 2005-10-25 2017-03-20 Starpharma Pty Ltd Composto macromolecular tendo estequiometria controlada
US11091786B2 (en) 2015-10-01 2021-08-17 Nanyang Technological University Butelase-mediated peptide ligation
WO2017120098A1 (en) * 2016-01-06 2017-07-13 University Of Florida Research Foundation, Inc. Stimuli-responsive polymeric nanoparticles, methods of making stimuli-responsive polymeric nanoparticles, and methods of using stimuli-responsive polymeric nanoparticles
WO2018017954A1 (en) * 2016-07-21 2018-01-25 Rutgers, The State University Of New Jersey Antimicrobial cationic systems and methods of use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2154240A (en) * 1984-01-27 1985-09-04 Univ New York Immunodominant epitope of the circumsporozoite surface protein
WO1987000533A1 (en) * 1985-07-12 1987-01-29 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
EP0275196A2 (de) * 1987-01-14 1988-07-20 Manuel E. Patarroyo Malaria-Impfstoff aus copolymerem Protein
EP0343460A2 (de) * 1988-05-24 1989-11-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Cs-Peptide von P. Falciparum als allgemeines t-Zellen-Epitop

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289872A (en) * 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2154240A (en) * 1984-01-27 1985-09-04 Univ New York Immunodominant epitope of the circumsporozoite surface protein
WO1987000533A1 (en) * 1985-07-12 1987-01-29 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
EP0275196A2 (de) * 1987-01-14 1988-07-20 Manuel E. Patarroyo Malaria-Impfstoff aus copolymerem Protein
EP0343460A2 (de) * 1988-05-24 1989-11-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Cs-Peptide von P. Falciparum als allgemeines t-Zellen-Epitop

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9011778A1 *

Also Published As

Publication number Publication date
EP0423315A1 (de) 1991-04-24
WO1990011778A1 (en) 1990-10-18
AU5649290A (en) 1990-11-05
CA2031197A1 (en) 1990-10-13
JPH03503539A (ja) 1991-08-08

Similar Documents

Publication Publication Date Title
EP0423315A4 (en) Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
HU9201966D0 (en) An improved vaccine of meningococcus-polysaccharide conjunction
HUT57264A (en) Process for producing turkey- recombinant herpes virus and living vector vaccine from them
FR2629717B1 (fr) Preparation de vaccin
AU5079290A (en) Sustained release pharmaceutical preparation
ATA144090A (de) Formulierungen mit verlangsamter freisetzung wasserlöslicher peptide
AU6155790A (en) Lactam-containing compositions and methods useful for the extraction of nucleic acids
AU1380788A (en) Synthetic peptide antigens for the detection of hiv-1 infection
GB8829896D0 (en) Preparation of modified star polymers
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
IL94558A0 (en) Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
EP0275196A3 (en) Protein copolymer malaria vaccine
ZA88197B (en) Protein copolymer malaria vaccine
AU6777490A (en) Malaria vaccine
AU5836390A (en) Human lymphoma-associated virus
AP9000165A0 (en) Vaccine composition
AU630186B2 (en) Canine corona virus vaccine
HU902652D0 (en) Process for the preparation of malaria vaccine
AU8067187A (en) Method for preparation of tastable matters consisting mainly of low molecular weight peptides
GB2200642B (en) Small molecular weight antigen of plasmodium falciparum
GB2248186B (en) Preparation of vaccines
AU7163091A (en) Novel malarial sporozoite peptide antigens
IL89433A0 (en) Theatre system
AU7698287A (en) Small molecular weight antigen of plasmodium falciparum
EP0486507A4 (en) Anthelmintic non-living vaccine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19901211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19910923

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19921105